EUVIMEDEUVIMED entdecken
Crossref

Nanoviricides Platform Technology Based NV-387 Polymer Protects Remdesivir from Plasma-Mediated Catabolism In vitro: Importance of its Increased Lifetime for In vivo Action

Ashok Chakraborty, Anil Diwan, Vinod Arora, Yogesh Thakur, Preetam Holkar, Vijetha Chiniga

Recent Advances in Clinical Trials · 2021

DOI: 10.33425/2771-9057.1004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Advances in Clinical Trials, 2021. Verfasst von Ashok Chakraborty und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As of today, seven coronaviruses were identified to infect humans, out of which only 4 of them belongs to beta family of coronavirus, like HCoV-HKU1, SARS-CoV-2, MERS-CoV and SARS-CoV. SARS family of viruses were known to cause severe respiratory disease in humans. SARS-CoV-2 infection causes pandemic COVID-19 disease with high morbidity and mortality. Remdesivir (RDV) is the only antiviral drug so far approved for COVID-19 therapy by FDA. However, it’s efficacy is limited in vivo due to its low stability in presence of Plasma. Here we show the stability of RDV encapsulated with our platform technology based polymer NV-387 (NV-CoV- 2-R), in presence of Plasma in vitro in comparison to naked RDV when incubated in plasma. The potential use of this polymer in vivo will be discussed, here.

Zitieren

APA

Chakraborty, A., Diwan, A., Arora, V., Thakur, Y., Holkar, P., & Chiniga, V. (2021). Nanoviricides Platform Technology Based NV-387 Polymer Protects Remdesivir from Plasma-Mediated Catabolism In vitro: Importance of its Increased Lifetime for In vivo Action. Recent Advances in Clinical Trials. https://doi.org/10.33425/2771-9057.1004

Vancouver

Chakraborty A, Diwan A, Arora V, Thakur Y, Holkar P, Chiniga V. Nanoviricides Platform Technology Based NV-387 Polymer Protects Remdesivir from Plasma-Mediated Catabolism In vitro: Importance of its Increased Lifetime for In vivo Action. Recent Advances in Clinical Trials. 2021. doi:10.33425/2771-9057.1004

BibTeX
@article{Chakraborty2021,
  author = {Chakraborty, Ashok and Diwan, Anil and Arora, Vinod and Thakur, Yogesh and Holkar, Preetam and Chiniga, Vijetha},
  title = {Nanoviricides Platform Technology Based NV-387 Polymer Protects Remdesivir from Plasma-Mediated Catabolism In vitro: Importance of its Increased Lifetime for In vivo Action},
  journal = {Recent Advances in Clinical Trials},
  year = {2021},
  doi = {10.33425/2771-9057.1004}
}
Kostenlos starten →